Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

6.1K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.1K
Glial Cells01:04

Glial Cells

92.0K
Overview
92.0K
Organization of the Nervous System01:13

Organization of the Nervous System

8.9K
The nervous system is one of the most complex systems in our body. It is organized into two main divisions: the central nervous system (CNS) and the peripheral nervous system (PNS).
The CNS, comprising the brain and spinal cord, houses billions of neurons. The brain is housed in the skull, while the spinal cord is linked to the brain through the foramen magnum of the occipital bone and is surrounded by the protective structure of the vertebral column. It is responsible for processing various...
8.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breaking Barriers in Leptomeningeal Disease: A SNO-ASCO Consensus Review on Clinical Trial Design and Basic Science Integration.

Neuro-oncology·2026
Same author

The evolving landscape of brain metastasis: volume II.

Trends in cancer·2025
Same author

Inflammation accelerates metastasis: Medulloblastoma leptomeningeal dissemination.

Developmental cell·2025
Same author

Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025
Same author

Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses.

Science translational medicine·2025
Same author

Only the strong survive: therapeutic selective pressure drives medulloblastoma leptomeningeal metastasis.

Molecular oncology·2025

Related Experiment Video

Updated: Nov 27, 2025

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

27.7K

Metastasis to the Central Nervous System.

Adrienne Boire

    Continuum (Minneapolis, Minn.)
    |December 4, 2020
    PubMed
    Summary

    Advances in molecular characterization and targeted therapies are improving outcomes for patients with central nervous system (CNS) metastasis. Novel diagnostic techniques and personalized treatments offer new hope for managing brain and spinal cord tumors.

    Area of Science:

    • Neuro-oncology
    • Translational Medicine
    • Genomics

    Background:

    • Central nervous system (CNS) metastasis management has advanced significantly.
    • Molecular characterization of metastatic disease is now standard practice.
    • Targeted therapies for CNS metastasis have expanded and improved CNS penetration.

    Purpose of the Study:

    • To review recent advancements in the evaluation and clinical management of CNS metastasis.
    • To highlight the impact of molecular profiling on treatment strategies.
    • To discuss emerging diagnostic and therapeutic approaches.

    Main Methods:

    • Utilizing novel diagnostic techniques, including liquid biopsies (spinal fluid molecular analysis).
    • Performing genomic sequencing on resected CNS metastases.

    More Related Videos

    Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
    07:14

    Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

    Published on: May 23, 2025

    1.1K
    Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
    06:44

    Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

    Published on: June 7, 2020

    7.7K

    Related Experiment Videos

    Last Updated: Nov 27, 2025

    Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
    07:43

    Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

    Published on: February 8, 2017

    27.7K
    Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
    07:14

    Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

    Published on: May 23, 2025

    1.1K
    Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
    06:44

    Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

    Published on: June 7, 2020

    7.7K
  • Reviewing current literature on targeted therapies, immunotherapy, and radiation techniques.

    • Main Results:

    • Molecular analysis enables precise characterization of CNS metastases.
    • Targetable mutations in CNS metastases open avenues for oral targeted therapies or immunotherapy.
    • Stereotactic radiosurgery is increasingly preferred over whole-brain radiation therapy for localized lesions.
    • Improved progression-free and overall survival observed with new diagnostic and therapeutic approaches.

    Conclusions:

    • Technological progress has revolutionized CNS metastasis diagnosis and management.
    • Personalized medicine approaches are enhancing patient outcomes.
    • Future directions involve further integration of molecular data into clinical decision-making.